Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome®-system 11g/8g vs. ATEC®-system 12g/9g

Schaefer, Fritz; Order, B.; Eckmann-Scholz, Christel; Strauß, Alexander; Hilpert, Felix; Kroj, K; Biernath-Wüpping, Julia; Heller, Martin; Jonat, W.; Schaefer, Philipp J.

doi:10.1016/j.ejrad.2012.01.033

Cited by 22 publications

(17 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pagni et al reported the haematoma rate 9% (62/712) with 8‐, 11‐, or 14‐gauge Mammotome probes . Furthermore, considering the different needle sizes of VABB, a previous study indicated that bleedings and haematomas for 8‐gauge Mammotome system were significantly more than that following 11‐gauge Mammotome system (41.9% vs 8.4%, P < .001; 35.5% vs 16.7%, P = .029) . Most haematomas recorded were minimal, and they could be gradually resolved without special management.…”

Section: Discussionmentioning

confidence: 96%

Feasibility and safety of image‐guided vacuum‐assisted breast biopsy: A PRISMA‐compliant systematic review and meta‐analysis of 20 000 population from 36 longitudinal studies

Fang

Liu

Luo

et al. 2019

International Wound Journal

View full text Add to dashboard Cite

Breast cancer is a serious disease in women. We estimated the global technical success rate and complication rates of percutaneous vacuum‐assisted breast biopsy (VABB). PubMed, Embase, Web of Science, and Scopus databases were retrieved up to July 2018 to find studies in which technical success rate and complication rates of VABB were available. Pooled rates were calculated according to location mode (ultrasonography [US] or mammography) and needle type (8‐ or 11‐gauge Mammotome probes). Of the 36 articles with 20 868 cases, we found the pooled technical success rate 0.9999(0.9997, 1.0000) (I2 = 17.1%, P = .187) and low complication risks including haematoma 0.1092(0.0748, 0.1437) (I2 = 98.3%, P < .001), pain 0.0738(0.0334, 0.1141) (I2 = 95.9%, P < .001), vasovagal reflex 0.0281(0.0035, 0.0527) (I2 = 92.5%, P < .001), and infection 0.0027(−0.0019, 0.0073) (I2 = 49.8%, P = .113). In this systematic review and meta‐analysis, the pooled data suggested that VABB with US or mammography could be promising for diagnosis and treatment of breast disease. Further studies were necessary to identify strategies for these findings.

show abstract

Section: Discussionmentioning

confidence: 96%

Feasibility and safety of image‐guided vacuum‐assisted breast biopsy: A PRISMA‐compliant systematic review and meta‐analysis of 20 000 population from 36 longitudinal studies

Fang

Liu

Luo

et al. 2019

International Wound Journal

View full text Add to dashboard Cite

show abstract

“…The use of smaller 11-gauge SVAB devices may decrease post-procedure bleeding and haematoma formation, although evidence suggests that this effect is device dependent. Schaefer et al 19 showed that the 11-gauge Mammotome® system had a significantly lower haematoma rate than the 8-gauge Mammotome®. At our institution, the Hologic Eviva nine-gauge SVAB system is used for all breast biopsies and is preferred over smaller gauge devices in an attempt to limit sampling error.…”

Section: Discussionmentioning

confidence: 99%

A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers

Pinkney

Mychajlowycz

Shah

2016

BJR

View full text Add to dashboard Cite

“…In stereotactic biopsy, the reported imaging-histologic discordance rate ranges from 3.1 to 6.2%. When the subsequent procedure (surgical excision or repeat biopsy) has been performed at the discordant lesion after stereotactic biopsy, the frequency of malignancy ranged from 0 to 64% (7,20,(23)(24)(25). In this study, imaging histologic discordance of ST-VAB is 22.7%.…”

Section: Discussionmentioning

confidence: 77%

“…Use of an 8-gauge needle can improve diagnostic performance in comparison with an 11-gauge needle (4). However, increasing the needle size is associated with greater risk of bleeding and hematoma formation, so it is necessary to select the needle size appropriate for each application (20). In this study, an 8-gauge needle was used in cases in which the extent of microcalcifications was > 10 mm, while an 11-gauge needle was used in those with less extensive microcalcifications < 10 mm.…”

Section: Discussionmentioning

confidence: 99%

Vacuum Assisted-Biopsy and Mammo-Guided Localization and Excisional Biopsy in the Microcalcifications Sampling of Breast: An Experience of Single Institution

Park

Sohn

2016

Iran J Radiol

View full text Add to dashboard Cite

Background: Sterotactic vacuum assisted biopsy (ST-VAB) is safe and effective method for nonpalpable mammographically visible microcalcifications or masses. ST-VAB is less invasive and is associated with less scar formation than surgical excision. Also ST-VAB can avoid unnecessary additional surgery. But ST-VAB has possibility of histologic underestimation of high-risk lesions such as atypical ductal hyperplasia and atypical lobular hyperplasia. Objectives: To evaluate the outcome of ST-VAB and mammography-guided localization and excisional biopsy (MGL-EB) for microcalcifications. Patients and Methods: Two radiologists retrospectively reviewed the medical records of patients who underwent breast biopsy for microcalcification from January 2011 to March 2013. They underwent ST-VAB (n = 22) and MGL-EB (n = 34). The clinicoradiological factors of two groups were evaluated, respectively. The malignancy rate and imaging histologic discordant rate in the two groups were assessed. We evaluated follow-up studies of all patients for newly developed or missed breast cancer. Results: The malignancy rates were 13.6% (3/22) for ST-VAB and 17.6% (6/34) for MGL-EB, respectively. Subsequent surgery was performed in five patients (n = 3, ST-VAB; n = 2, MGL-EB) and they were all confirmed as ductal carcinoma in situ. The discordant rates were 22.7 % (5/22) for ST-VAB and 14.7 % (5/34) for MGL-EB after imaging-histologic correlation. There was no malignancy detected on follow up studies. Conclusion: ST-VAB and MGL-EB are reliable biopsy methods for microcalcifications. In proper indications, breast microcalcifications could be obtained by each method without missing diagnosis of breast cancer.

show abstract

Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome®-system 11g/8g vs. ATEC®-system 12g/9g

Cited by 22 publications

References 14 publications

Feasibility and safety of image‐guided vacuum‐assisted breast biopsy: A PRISMA‐compliant systematic review and meta‐analysis of 20 000 population from 36 longitudinal studies

Feasibility and safety of image‐guided vacuum‐assisted breast biopsy: A PRISMA‐compliant systematic review and meta‐analysis of 20 000 population from 36 longitudinal studies

A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers

Vacuum Assisted-Biopsy and Mammo-Guided Localization and Excisional Biopsy in the Microcalcifications Sampling of Breast: An Experience of Single Institution

Contact Info

Product

Resources

About